Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT)

Historical Holders from Q2 2019 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
ARCT on Nasdaq
Shares outstanding
28,406,191
Price per share
$6.13
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
25,813,853
Holdings value
$475,545,761
% of all portfolios
0%
Share change
+50,564
Value change
+$6,867,356
Average buys %
+0%
Average sells %
-0%
Number of holders
134
Price from insider filings
$16.56
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FEDERATED HERMES, INC. 12% $20,250,983 3,303,640 Federated Hermes, Inc. 31 Dec 2025
BALYASNY ASSET MANAGEMENT L.P. 8% $40,250,844 2,183,985 Balyasny Asset Management L.P. 30 Sep 2025
BlackRock, Inc. 7.8% $27,169,573 2,104,537 BlackRock, Inc. 31 Mar 2025
Sumitomo Mitsui Trust Group, Inc. 7.2% +1.4% $35,898,599 +$400,871 1,947,835 +1.1% Sumitomo Mitsui Trust Group, Inc. 30 Sep 2025
Amova Asset Management Americas, Inc. 7.2% +1.4% $35,898,599 +$400,871 1,947,835 +1.1% Amova Asset Management Americas, Inc. 30 Sep 2025
VANGUARD GROUP INC 6.7% $23,550,428 1,810,165 The Vanguard Group 30 Jun 2025
ARK Investment Management LLC 6.3% $22,312,842 1,715,040 ARK Investment Management LLC 30 Jun 2025
STATE STREET CORP 4.9% $17,120,700 1,326,158 STATE STREET CORPORATION 31 Dec 2024
As of 30 Sep 2025, Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) has 134 institutional shareholders filing 13F forms. They hold 25,813,853 shares of 28,406,191 outstanding shares (91%) .

Top 25 institutional shareholders own 82% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
FEDERATED HERMES, INC. 17% 4,694,060 0% 0.15% $86,511,526
BlackRock, Inc. 9% 2,564,644 -2.9% 0% $47,266,388
Sumitomo Mitsui Trust Group, Inc. 6.9% 1,947,835 +6.3% 0.02% $35,898,599
Amova Asset Management Americas, Inc. 6.9% 1,947,835 +6.4% 0.35% $35,879,121
VANGUARD GROUP INC 6.6% 1,885,605 +4.2% 0% $34,751,700
ARK Investment Management LLC 6.6% 1,872,721 +9.2% 0.21% $34,514,252
STATE STREET CORP 3.7% 1,045,681 +2.5% 0% $19,271,901
Balyasny Asset Management L.P. 3.4% 964,985 +12% 0.04% $17,784,674
MORGAN STANLEY 2.5% 704,878 +17% 0% $12,990,901
Schonfeld Strategic Advisors LLC 2.4% 667,827 -15% 0.09% $12,308,048
BANK OF AMERICA CORP /DE/ 2.2% 620,055 +112% 0% $11,427,614
GEODE CAPITAL MANAGEMENT, LLC 2.2% 611,823 +0.91% 0% $11,278,373
DIMENSIONAL FUND ADVISORS LP 2% 555,414 -4.6% 0% $10,236,963
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.9% 552,179 +1371% 0.01% $10,176,659
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1.9% 533,985 +336% 0.01% $9,841,344
Empire Life Investments Inc. 1.5% 417,563 +58% 0.45% $7,695,686
JACOBS LEVY EQUITY MANAGEMENT, INC 1.1% 305,659 -38% 0.02% $5,633,295
ACADIAN ASSET MANAGEMENT LLC 0.83% 236,345 +71% 0.01% $4,353,000
NORTHERN TRUST CORP 0.77% 217,834 -1.4% 0% $4,014,681
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.74% 209,456 +10% 0% $3,860,274
JPMORGAN CHASE & CO 0.72% 203,607 -1.6% 0% $3,752,477
UBS Group AG 0.56% 160,486 +189% 0% $2,957,756
GOLDMAN SACHS GROUP INC 0.51% 144,728 -77% 0% $2,667,337
JANE STREET GROUP, LLC 0.48% 136,390 0% $2,513,667
FMR LLC 0.47% 133,875 -26% 0% $2,467,325

Institutional Holders of Arcturus Therapeutics Holdings Inc. - COMMON STOCK (ARCT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 29,014 $177,856 -$104,789 $6.13 4
2025 Q3 25,813,853 $475,545,761 +$6,867,356 $18.43 134
2025 Q2 25,723,468 $335,038,354 -$6,831,289 $13.01 140
2025 Q1 26,575,062 $281,454,102 -$6,198,440 $10.59 141
2024 Q4 26,610,345 $451,455,958 +$561,441 $16.97 144
2024 Q3 26,254,849 $609,261,942 -$9,219,231 $23.21 163
2024 Q2 26,274,363 $639,738,709 -$34,874,203 $24.35 169
2024 Q1 27,205,455 $918,443,053 +$63,004,519 $33.77 176
2023 Q4 25,425,877 $801,644,603 +$9,906,113 $31.53 165
2023 Q3 25,171,045 $643,113,548 +$38,194,974 $25.55 146
2023 Q2 23,633,969 $677,565,419 +$11,461,734 $28.68 143
2023 Q1 23,320,944 $557,885,187 +$17,248,370 $23.97 124
2022 Q4 22,638,074 $383,920,663 +$11,521,684 $16.96 111
2022 Q3 22,166,410 $328,065,176 -$1,828,982 $14.82 106
2022 Q2 20,644,930 $334,480,556 +$9,251,825 $15.74 116
2022 Q1 21,454,944 $578,272,039 +$36,976,142 $26.96 122
2021 Q4 19,955,158 $736,203,155 +$29,436,784 $37.01 133
2021 Q3 19,065,552 $909,015,330 -$50,289,411 $47.78 150
2021 Q2 20,506,601 $693,959,237 +$36,673,317 $33.84 133
2021 Q1 18,787,112 $775,920,001 -$48,861,238 $41.30 153
2020 Q4 19,874,000 $864,074,837 +$70,349,611 $43.38 131
2020 Q3 18,215,804 $783,103,294 +$221,938,988 $42.90 127
2020 Q2 12,949,979 $605,805,587 +$388,736,954 $46.74 112
2020 Q1 4,735,510 $65,692,000 +$2,316,123 $13.59 53
2019 Q4 4,554,811 $50,089,000 -$172,871 $10.87 49
2019 Q3 4,612,453 $47,342,000 +$27,908,866 $10.27 39
2019 Q2 1,877,652 $17,728,000 +$17,719,999 $9.44 20